S&P 500   4,657.76 (+1.37%)
DOW   35,153.41 (+0.73%)
QQQ   398.86 (+1.96%)
AAPL   160.38 (+2.28%)
MSFT   338.00 (+2.52%)
FB   337.81 (+1.41%)
GOOGL   2,901.33 (+2.03%)
AMZN   3,575.86 (+2.03%)
TSLA   1,134.88 (+4.90%)
NVDA   329.68 (+4.65%)
BABA   131.98 (-1.03%)
NIO   40.16 (+0.43%)
CGC   11.03 (-5.65%)
AMD   159.03 (+2.73%)
GE   97.59 (-0.26%)
MU   84.83 (+1.69%)
T   23.89 (-1.36%)
F   19.71 (-0.20%)
DIS   145.13 (-2.01%)
ACB   6.43 (-5.30%)
AMC   36.48 (-3.06%)
PFE   53.69 (-0.57%)
BA   196.95 (-1.13%)
S&P 500   4,657.76 (+1.37%)
DOW   35,153.41 (+0.73%)
QQQ   398.86 (+1.96%)
AAPL   160.38 (+2.28%)
MSFT   338.00 (+2.52%)
FB   337.81 (+1.41%)
GOOGL   2,901.33 (+2.03%)
AMZN   3,575.86 (+2.03%)
TSLA   1,134.88 (+4.90%)
NVDA   329.68 (+4.65%)
BABA   131.98 (-1.03%)
NIO   40.16 (+0.43%)
CGC   11.03 (-5.65%)
AMD   159.03 (+2.73%)
GE   97.59 (-0.26%)
MU   84.83 (+1.69%)
T   23.89 (-1.36%)
F   19.71 (-0.20%)
DIS   145.13 (-2.01%)
ACB   6.43 (-5.30%)
AMC   36.48 (-3.06%)
PFE   53.69 (-0.57%)
BA   196.95 (-1.13%)
S&P 500   4,657.76 (+1.37%)
DOW   35,153.41 (+0.73%)
QQQ   398.86 (+1.96%)
AAPL   160.38 (+2.28%)
MSFT   338.00 (+2.52%)
FB   337.81 (+1.41%)
GOOGL   2,901.33 (+2.03%)
AMZN   3,575.86 (+2.03%)
TSLA   1,134.88 (+4.90%)
NVDA   329.68 (+4.65%)
BABA   131.98 (-1.03%)
NIO   40.16 (+0.43%)
CGC   11.03 (-5.65%)
AMD   159.03 (+2.73%)
GE   97.59 (-0.26%)
MU   84.83 (+1.69%)
T   23.89 (-1.36%)
F   19.71 (-0.20%)
DIS   145.13 (-2.01%)
ACB   6.43 (-5.30%)
AMC   36.48 (-3.06%)
PFE   53.69 (-0.57%)
BA   196.95 (-1.13%)
S&P 500   4,657.76 (+1.37%)
DOW   35,153.41 (+0.73%)
QQQ   398.86 (+1.96%)
AAPL   160.38 (+2.28%)
MSFT   338.00 (+2.52%)
FB   337.81 (+1.41%)
GOOGL   2,901.33 (+2.03%)
AMZN   3,575.86 (+2.03%)
TSLA   1,134.88 (+4.90%)
NVDA   329.68 (+4.65%)
BABA   131.98 (-1.03%)
NIO   40.16 (+0.43%)
CGC   11.03 (-5.65%)
AMD   159.03 (+2.73%)
GE   97.59 (-0.26%)
MU   84.83 (+1.69%)
T   23.89 (-1.36%)
F   19.71 (-0.20%)
DIS   145.13 (-2.01%)
ACB   6.43 (-5.30%)
AMC   36.48 (-3.06%)
PFE   53.69 (-0.57%)
BA   196.95 (-1.13%)
NASDAQ:TRUP

Trupanion Stock Forecast, Price & News

$123.59
-3.20 (-2.52%)
(As of 11/29/2021 12:03 PM ET)
Add
Compare
Today's Range
$119.98
$126.79
50-Day Range
$76.95
$137.73
52-Week Range
$69.74
$140.46
Volume
6,676 shs
Average Volume
350,131 shs
Market Capitalization
$4.99 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.98
30 days | 90 days | 365 days | Advanced Chart
Receive TRUP News and Ratings via Email

Sign-up to receive the latest news and ratings for Trupanion and its competitors with MarketBeat's FREE daily newsletter.


Trupanion logo

About Trupanion

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members and contracts include multiple pets. The company was founded by Darryl Rawlings in January 2000 and is headquartered in Seattle, WA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:TRUP
Employees
911
Year Founded
N/A

Sales & Book Value

Annual Sales
$502.03 million
Cash Flow
$0.03 per share
Book Value
$8.22 per share

Profitability

Net Income
$-5.84 million
Pretax Margin
-5.05%

Debt

Price-To-Earnings

Miscellaneous

Free Float
37,635,000
Market Cap
$4.99 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/03/2021
Today
11/29/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/09/2022

MarketRank

Overall MarketRank

1.84 out of 5 stars

Finance Sector

802nd out of 1,340 stocks

Hospital & Medical Service Plans Industry

11th out of 13 stocks

Analyst Opinion: 1.4Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -












Trupanion (NASDAQ:TRUP) Frequently Asked Questions

Is Trupanion a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Trupanion stock.
View analyst ratings for Trupanion
or view top-rated stocks.

How has Trupanion's stock price been impacted by COVID-19?

Trupanion's stock was trading at $26.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TRUP stock has increased by 374.6% and is now trading at $123.59.
View which stocks have been most impacted by COVID-19
.

When is Trupanion's next earnings date?

Trupanion is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Trupanion
.

How were Trupanion's earnings last quarter?

Trupanion, Inc. (NASDAQ:TRUP) posted its quarterly earnings results on Wednesday, November, 3rd. The financial services provider reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.01. Trupanion had a negative net margin of 4.94% and a negative trailing twelve-month return on equity of 8.69%. During the same period last year, the company posted ($0.07) earnings per share.
View Trupanion's earnings history
.

What price target have analysts set for TRUP?

5 analysts have issued 1-year price objectives for Trupanion's stock. Their forecasts range from $100.00 to $150.00. On average, they anticipate Trupanion's stock price to reach $127.80 in the next twelve months. This suggests a possible upside of 3.4% from the stock's current price.
View analysts' price targets for Trupanion
or view top-rated stocks among Wall Street analysts.

Who are Trupanion's key executives?

Trupanion's management team includes the following people:

What is Darryl Rawlings' approval rating as Trupanion's CEO?

139 employees have rated Trupanion CEO Darryl Rawlings on Glassdoor.com. Darryl Rawlings has an approval rating of 76% among Trupanion's employees.

Who are some of Trupanion's key competitors?

What other stocks do shareholders of Trupanion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), Micron Technology (MU), Chipotle Mexican Grill (CMG), McEwen Mining (MUX), Pfizer (PFE), Splunk (SPLK), AbbVie (ABBV), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

What is Trupanion's stock symbol?

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

Who are Trupanion's major shareholders?

Trupanion's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.24%), Wellington Management Group LLP (5.67%), Baillie Gifford & Co. (3.53%), Alliancebernstein L.P. (3.26%), Geode Capital Management LLC (1.81%) and Morgan Stanley (1.30%). Company insiders that own Trupanion stock include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Michael Doak, Murray B Low, Robin A Ferracone and Tricia Plouf.
View institutional ownership trends for Trupanion
.

Which major investors are selling Trupanion stock?

TRUP stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, BlackRock Inc., Avenir Corp, Karani Asset Management LLC, Wellington Management Group LLP, Allianz Asset Management GmbH, Capital Research Global Investors, and Two Sigma Advisers LP. Company insiders that have sold Trupanion company stock in the last year include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Michael Doak, Murray B Low, and Tricia Plouf.
View insider buying and selling activity for Trupanion
or view top insider-selling stocks.

Which major investors are buying Trupanion stock?

TRUP stock was bought by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Pura Vida Investments LLC, Tsai Capital Corp, Millennium Management LLC, Cinctive Capital Management LP, Dimensional Fund Advisors LP, Voloridge Investment Management LLC, and Twinbeech Capital LP.
View insider buying and selling activity for Trupanion
or or view top insider-buying stocks.

How do I buy shares of Trupanion?

Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trupanion's stock price today?

One share of TRUP stock can currently be purchased for approximately $123.59.

How much money does Trupanion make?

Trupanion has a market capitalization of $4.99 billion and generates $502.03 million in revenue each year. The financial services provider earns $-5.84 million in net income (profit) each year or ($0.80) on an earnings per share basis.

How many employees does Trupanion have?

Trupanion employs 911 workers across the globe.

What is Trupanion's official website?

The official website for Trupanion is www.trupanion.com.

Where are Trupanion's headquarters?

How can I contact Trupanion?

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at (888) 733-2685, via email at [email protected], or via fax at 866-405-4536.


This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.